rs1554533211
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_152419.3(HGSNAT):c.947G>A(p.Trp316Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,448,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_152419.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGSNAT | NM_152419.3 | c.947G>A | p.Trp316Ter | stop_gained | 10/18 | ENST00000379644.9 | NP_689632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGSNAT | ENST00000379644.9 | c.947G>A | p.Trp316Ter | stop_gained | 10/18 | 2 | NM_152419.3 | ENSP00000368965 | P3 | |
HGSNAT | ENST00000524016.5 | c.53G>A | p.Trp18Ter | stop_gained | 1/7 | 4 | ENSP00000428322 | |||
HGSNAT | ENST00000522082.5 | c.188G>A | p.Trp63Ter | stop_gained | 3/6 | 4 | ENSP00000430151 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1448728Hom.: 0 Cov.: 30 AF XY: 0.0000153 AC XY: 11AN XY: 719846
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-C Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 22, 2017 | - - |
Mucopolysaccharidosis, MPS-III-C;C4225287:Retinitis pigmentosa 73 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 29, 2023 | This sequence change creates a premature translational stop signal (p.Trp316*) in the HGSNAT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HGSNAT are known to be pathogenic (PMID: 17033958, 19479962). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis IIIC (PMID: 17033958, 28468868). ClinVar contains an entry for this variant (Variation ID: 553494). For these reasons, this variant has been classified as Pathogenic. - |
Sanfilippo syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 14, 2020 | Variant summary: HGSNAT c.947G>A (p.Trp316X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 239666 control chromosomes (gnomAD). c.947G>A has been reported in the literature in individuals affected with Mucopolysaccharidosis Type IIIC (Sanfilippo Syndrome C) (e.g. Hrebicek_2006, Ghosh_2017). These data indicate that the variant may be associated with disease. Experimental evidence indicated deficient HGSNAT activity in leukocytes of a compound heterozygous patient with the variant (Ghosh_2017). A ClinVar submitter (evaluation after 2014) cites the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at